Long term data presented at ESC 2010 shed further light on the benefit of the Cypher Sirolimus Drug-Eluting Stent compared to the Endeavor Zotarolimus-Eluting Stent in important high-risk subgroups

BRIDGEWATER, N.J. - Three new analyses of subgroups from the SORT OUT III study presented at the European Society of Cardiology (ESC) meeting in Stockholm, Sweden, provide additional detail on longer-...

read more

 

Please choose:

 RSS Feed | more news

International News